NCT00378339

Brief Summary

Gold implantation around arthritic joints is a very popular treatment - but the effect has never been controlled.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2009

Typical duration for phase_2

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

September 20, 2006

Completed
2.3 years until next milestone

Study Start

First participant enrolled

January 1, 2009

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2012

Completed
Last Updated

March 31, 2014

Status Verified

March 1, 2014

Enrollment Period

3.8 years

First QC Date

September 19, 2006

Last Update Submit

March 28, 2014

Conditions

Arthritis

Keywords

arthrosisgold

Outcome Measures

Primary Outcomes (1)

  • VAS

Secondary Outcomes (1)

  • WOMAC

Interventions

gold berlocksDEVICE

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Arthrosis in knee joint

You may not qualify if:

  • Need for NSAID

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Northern Orthopaedic Division, Klinik Frederikshavn

Frederikshavn, Northern Jutland, Denmark

Location

MeSH Terms

Conditions

ArthritisOsteoarthritis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Mogens B Laursen, MD, Phd

    Northern Orthopaedic Division

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2006

First Posted

September 20, 2006

Study Start

January 1, 2009

Primary Completion

October 1, 2012

Study Completion

October 1, 2012

Last Updated

March 31, 2014

Record last verified: 2014-03

Locations

DK(1)